לינפארזה 100 מג ישראל - עברית - Ministry of Health

לינפארזה 100 מג

astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 100 mg - olaparib

לינפארזה 100 מג ישראל - עברית - Ministry of Health

לינפארזה 100 מג

astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 100 mg - olaparib

לינפארזה 150 מג ישראל - עברית - Ministry of Health

לינפארזה 150 מג

astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 150 mg - olaparib

לינפארזה 150 מג ישראל - עברית - Ministry of Health

לינפארזה 150 מג

astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 150 mg - olaparib

לוקלמה 10 גר ישראל - עברית - Ministry of Health

לוקלמה 10 גר

astrazeneca (israel) ltd - sodium zirconium cyclosilicate - אבקה להכנת תרחיף - sodium zirconium cyclosilicate 10 g/sachet - sodium zirconium cyclosilicate

לוקלמה 5 גר ישראל - עברית - Ministry of Health

לוקלמה 5 גר

astrazeneca (israel) ltd - sodium zirconium cyclosilicate - אבקה להכנת תרחיף - sodium zirconium cyclosilicate 5 g/sachet - sodium zirconium cyclosilicate

קרסטור   10 מג ישראל - עברית - Ministry of Health

קרסטור 10 מג

astrazeneca (israel) ltd - rosuvastatin as calcium - טבליות מצופות פילם - rosuvastatin as calcium 10 mg - rosuvastatin - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

קרסטור   20 מג ישראל - עברית - Ministry of Health

קרסטור 20 מג

astrazeneca (israel) ltd - rosuvastatin as calcium - טבליות מצופות פילם - rosuvastatin as calcium 20 mg - rosuvastatin - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

קרסטור   40 מג ישראל - עברית - Ministry of Health

קרסטור 40 מג

astrazeneca (israel) ltd - rosuvastatin as calcium - טבליות מצופות פילם - rosuvastatin as calcium 40 mg - rosuvastatin - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

 קרסטור  5 מג ישראל - עברית - Ministry of Health

קרסטור 5 מג

astrazeneca (israel) ltd - rosuvastatin as calcium - טבליות מצופות פילם - rosuvastatin as calcium 5 mg - rosuvastatin - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction ) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.